Update on the Secured Loan Note Offer

Posted on: Wednesday, September 02, 2009

Capitalised terms used but not defined in this announcement shall have the meanings given to them in the circular sent to shareholders on 25 June 2009 (as amended by the circular sent to shareholders on 5 August 2009 (the "Second Circular")).

Following extensive discussions with Shareholders, the Directors have resolved to amend the closing date of the SLN Offer. In accordance with Condition 13 of the Loan Notes, the Directors have resolved to amend the New Closing Date so that the SLN Offer will close at 5.00 pm on Friday 11 September 2009 and will not be open for acceptance beyond such time. The term "New Closing Date" in the Second Circular should be read as amended accordingly. Any applications in relation to the SLN Offer received after such time will not therefore be accepted.

Notwithstanding that the SLN Offer will close at 5.00 pm on 11 September 2009, provided that on such date the Directors resolve to proceed with completion of the SLN Offer (in accordance with the terms set out in the Second Circular), the directors intend to launch a second secured loan note offer (the "Series 2 SLN Offer") on substantially the same terms as the SLN Offer save that the proposed conversion price of any convertible loan notes offered in substitution for the loan notes to be issued pursuant to the Series 2 SLN Offer will be higher than 2p per share. The actual proposed conversion price will be announced by the Directors at the same time as documentation relating to the Series 2 SLN Offer is sent to shareholders.

Other current news items

Distribution Agreement for Menoflavon® in Jordan
Posted on: Tuesday, May 25, 2010

Kudos™ Licensing Agreement
Posted on: Friday, May 14, 2010

Distribution Agreement for Menoflavon® in Singapore
Posted on: Thursday, April 15, 2010

Meldex International PLC 2008 Financial Statements
Posted on: Thursday, January 07, 2010

Announcement: Execution of Memorandum of Understanding
Posted on: Tuesday, December 08, 2009

Distribution Agreement for Menoflavon® in the Netherlands
Posted on: Tuesday, November 03, 2009

Restoration of Registrar Services
Posted on: Thursday, October 15, 2009

Company Update
Posted on: Tuesday, October 13, 2009

Distribution Agreement for Menoflavon® in Canada
Posted on: Friday, October 02, 2009

Company Update
Posted on: Friday, September 25, 2009

Distribution Agreement for Menoflavon® in Austria
Posted on: Friday, September 18, 2009

Result of Annual General Meeting
Posted on: Friday, August 28, 2009

Distribution Agreement for Menoflavon® and Melprotect® in United Arab Emirates
Posted on: Monday, August 24, 2009

Secured Loan Note Update and Notice of AGM
Posted on: Wednesday, August 05, 2009

Secured Loan Note update
Posted on: Friday, July 24, 2009

Extension to Secured Loan Note offer deadline
Posted on: Wednesday, July 22, 2009

Appointment of Consultant Project Manager
Posted on: Thursday, July 16, 2009

Distribution Agreement for Menoflavon® in Germany
Posted on: Friday, July 10, 2009

Appointment of Consultant Project Manager
Posted on: Friday, July 10, 2009

Proceedings issued against former Directors
Posted on: Saturday, July 04, 2009

Collaboration Agreement for Meltums™ Pharma Development
Posted on: Thursday, July 02, 2009

Secured Loan Note Applications
Posted on: Wednesday, July 01, 2009

Menoflavon® Distribution Agreements
Posted on: Monday, June 29, 2009

Launch of Secured Loan Note Offer
Posted on: Thursday, June 25, 2009

Distribution Agreement for Menoflavon® in Belgium
Posted on: Wednesday, June 24, 2009

Company Update
Posted on: Monday, June 15, 2009

Product Availability Matrix
Posted on: Thursday, June 11, 2009

Cancellation of Share Options
Posted on: Wednesday, June 03, 2009

Oradisc™ Benzocaine now at Regulatory stage
Posted on: Tuesday, May 05, 2009

Hintz Joint Venture announcement
Posted on: Thursday, April 09, 2009